Skip to main content
. 2019 Aug;25(8):1501–1510. doi: 10.3201/eid2508.190222

Table 6. Total direct and attributable medical costs of hepatitis A, malaria, and enteric fever, Peel region, Ontario, Canada, 2012–2014*.

Category Peel region
Ontario
No. case-patients Total direct costs, $ Cost per case-patient, $, mean (range) Cost per control, $, mean (range) Attributable cost (95% CI), $ No. case-patients Total direct costs, $†
Overall 90-d cost
318
2,058,196
6,472 (0–59,358)
375 (0–42,213)
6,098 (5,328–6,868)

1,216
7,870,341
By disease
Hepatitis A 55 306,707 5,576 (0–59,358) 560 (0–42,213) 5,016 (2,414–7,619)
300 1,672,944
Malaria 122 613,488 5,029 (0–38,556) 471 (0–26,598) 4,558 (3,557–5,558) 612 3,077,497
Plasmodium vivax 43 230,487 ND ND 4,812 (2,675–6,949) ND ND
P. falciparum 59 297,106 ND ND 4,743 (3,588–5,898) ND ND
Other 20 85,895 ND ND 3,463 (1,397–5,528) ND ND
Enteric fever
141
1,138,002
8,071 (0–33,563)
219 (0–13,824)
7,852 (6,812–8,893)
304
2,453,566
Restricted to most relevant costs
Hepatitis A 55 233,771 4,250 (0–23,048) 266 (0–10,163) 3,984 (2,823–5,145) 300 1,275,117
Malaria 122 611,030 5,008 (0–37,335) 361 (0–17,626) 4,647 (3,593–5,701) 612 3,065,171
Enteric fever 141 1,029,311 7,300 (0–33,563) 211 (0–13,824) 7,089 (6,097–8,081) 304 2,219,224

*Cost given in 2015 Canadian dollars. Attributable cost indicates the additional cost for each case-patient. ND, not determined.
†Extrapolated by multiplying the number of cases in the province reported to Public Health Ontario for the same period by the mean cost per case-patient estimated by using Peel region data.